286836-09-7

Basic information

• Product Name: 7-bromo-4,5-difluoro-1-benzofuran
• Synonyms: 7-bromo-4,5-difluoro-1-benzofuran
• CAS NO: 286836-09-7
• Molecular Weight: 233.012
• Mol File: 286836-09-7.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 7-bromo-4,5-difluoro-1-benzofuran(CAS DataBase Reference)
• NIST Chemistry Reference: 7-bromo-4,5-difluoro-1-benzofuran(286836-09-7)
• EPA Substance Registry System: 7-bromo-4,5-difluoro-1-benzofuran(286836-09-7)

Safety Data

• Hazardous Substances Data: 286836-09-7(Hazardous Substances Data)

Upstream product

• 166281-37-4 2-bromo-4,5-difluorophenol 
• 286836-28-0 2-allyl-3-bromo-4-fluorophenol 
• 286836-10-0 2-(2-bromo-4,5-difluorophenoxy)-acetaldehyde diethyl acetal 
• 286836-22-4 2-allyl-3,4-difluoro-6-bromophenol 
• 286836-21-3 2-bromo-4,5-difluorophenyl allyl ether 
• 7252-83-7 1-bromo-2,2-dimethoxyethane 
• 286836-23-5 (2-hydroxy-3-bromo-5,6-difluorophenyl)acetaldehyde 

Downstream Products

• 325486-95-1 1-benzyl-3-methyl-4-hydroxy-4-(4,5-difluorobenzofuran-7-yl)piperidine 
• 325486-39-3 (4,5-difluorobenzofuran-7-yl)boronic acid 
• 325486-96-2 1-benzyl-3-methyl-4-(4,5-difluorobenzofuran-7-yl)-1,2,3,6-tetrahydropyridine 

Relevant articles and documents

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES

An object is to provide a novel compound which has a glycogen synthase activation ability, but activates a receptor PPAR to a low degree and is highly safe. Provided is a compound represented by the following general formula (I) or a pharmaceutically acceptable salt thereof: wherein Ar1 represents any one of the following rings (II) and (III): wherein R2 represents an alkyl group, and R3 represents a hydrogen atom or an alkyl group, and R1 represents any one of the following substituents (IV) and (V):

Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists

The present invention provides serotonergic aminoalkylbenzofurans of Formula (I): where R, R1, R2, R3, R4, R4′, R5, R5′, and R12 are as described in the specification.

BENZOFURYLPIPERAZINES AND BENZOFURYLHOMOPIPERAZINES: SEROTONIN AGONISTS

The present invention provides serotonergic benzofurylpiperazines of Formula I: where: A is a piperazine of formula: and R, R1, R2, R3, R4, R5, R5', R6, R6', R7, R7', R8, and R8' are as described in the specification.